Skip to main content
Advertisement

< Back to Article

Synthetic method of analogues for emerging infectious disease forecasting

Fig 5

The proportion of all models (black) and best-in-class models (red) sMOA outperforms in MAE (top) and WIS (bottom) if the validation window ranged from August 2020 through the x-axis date.

sMOA outperforms the majority of all models and best-in-class models if the validation date cut off is between October 2020 and March 2023. Directly before October 2020, there was a dip in incidence case counts that sMOA failed to forecast accurately that caused the initial lower performance.

Fig 5

doi: https://doi.org/10.1371/journal.pcbi.1013203.g005